"End of AIDS by 2030" if adequate funding is provided to frontline services: UN.

Published Date: 29 Nov 2023

According to the UN, it is still feasible to "end AIDS" by 2030—but only if local communities and services are provided with the necessary resources. This announcement was made on Tuesday.

Read Full News

Latest News

UK Commits $26.87 Million to Contain Ebola Outbreak in DRC

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

US Working With Small Biotech Firm on Experimental Ebola Treatment, HHS Official Says

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

Congenital CMV Linked to Substantial Long-Term Health Issues

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Why the Test-Negative Design Is Our Most Vital Tool for Vaccine Effectiveness

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Test Shortages Slow Fight Against Ebola in Congo, WHO Official Says

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird Flu Found in Polar Bear in Europe for First Time

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Britain has allocated up to 20 million pounds ($26.87 million) in ⁠new aid funding to help contain an Ebola outbreak in eastern ⁠Democratic Republic of the Congo, the UK's...

U.S. officials are working with Mapp Biopharmaceutical to make an experimental Ebola treatment available for people who may have been exposed to ⁠the virus, an HHS official...

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV infection.

Dr Daskalakis explains vaccine study designs and how the science of test negative design, a decades-old, tried and true design, is now being called into question.

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

News All Time

Biomarkers Spot Invasive Aspergillosis Post-Lung Transplant

RNA testing may help assess the consequences of common environmental mold.

South Africa: Brit With Hantavirus Gradually Improving

The condition of a British man who was admitted ⁠to a hospital in Johannesburg after falling ill with hantavirus aboard ⁠a luxury cruise ship is gradually improving.

Pregnancy vs Postpartum Flare Rates Differ in RA and SpA

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during pregnancy; however, flare rates in those with spondyloarthritis remain stable.

WHO Says Seven Cases Of Hantavirus Confirmed From Cruise Ship

Seven cases of the ⁠Andes hantavirus have now been confirmed among people ⁠who were passengers on board the ⁠cruise ship, the ‌World Health Organization said on...

A Child's First Flu May Set the Tone for Immunity

New research shows that a child's earliest encounter with the virus can 'imprint' the immune system, shaping how their antibodies respond to future infections.

First Lyme Vaccine in Decades Nears Approval

Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions.

Prior Maternal Syphilis Boosts Congenital Infection Risk

A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.

Telemedicine in Pediatric Care Tied to Lower Antibiotic Use

Primary care telemedicine visits for acute respiratory tract infections in children are associated with a lower rate of antibiotic prescriptions than in-person visits.

US CDC Classifies Hantavirus Outbreak as 'level 3' Emergency Response, ABC News Reports

The ⁠U.S. Centers ⁠for Disease ⁠Control and ‌Prevention has classified the hantavirus ‌outbreak as 'level 3' ‌emergency ‌response, the ⁠lowest ‌level ⁠of emergency...

Does Mycoplasma genitalium Cause Recurrent Preterm Birth?

Mycoplasma genitalium infection shows an association with prior spontaneous preterm birth but does not increase the risk for recurrent spontaneous preterm birth.

Moderna's MRNA Flu Vaccine Outperforms Standard Shot in Late-stage Trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged ⁠50 and older,...

CDC Says It Is Monitoring US Travelers on Cruise Ship After Hantavirus Outbreak

The United States is closely monitoring the situation with U.S. travelers on board the luxury cruise ship that was ⁠hit by a hantavirus outbreak, the Centers for Disease...

US FDA Blocked Publication of COVID, Shingles Vaccine Safety Studies

Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the ⁠safety of widely used vaccines against COVID-19 and shingles, a...

New Surveillance Study Supports Maternal RSV Vaccine Safety

Early data keep hypertension concerns on the radar, but more robust research shows no increased risk.

California's Highest Court Leans Toward Gilead in Considering Drugmakers' 'duty to Innovate'

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

Young Age, Lower BMI May Predict HIV Treatment Failure

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

Recommended News For You

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

How the skin cancer virus outperforms the replication of host cells.

BTK Inhibitor Active in Half of Patients With Richter Transformation

New Standard of Care in High-Risk Acute Promyelocytic Leukemia?

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy

Recommended Articles For You

Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies 

What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options 

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology 

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

2.

Glioblastoma treatment breakthrough shows promise

3.

A computer-aided diagnostic system for improved detection of breast cancer.

4.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

5.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

1.

Liquid Biopsies in Hematology: A Window into the Disease

2.

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology

3.

A Visual Guide to Understanding Breast Cancer Staging

4.

Exploring the Latest Treatments for Essential Thrombocythemia

5.

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

3.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

4.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

5.

Navigating the Complexities of Ph Negative ALL - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot